At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 27 enrolled
Drug / intervention
Atorvastatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of LY2189265 on the Pharmacokinetics of Atorvastatin in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating Atorvastatin and LY2189265 for Healthy Volunteers. Completed, enrolled 27 participants across 1 site.
Detailed Summary
This study will assess if giving LY2189265 at the same time as atorvastatin affects how the body absorbs atorvastatin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 2010
Enrollment StartDec 2010
Primary CompletionMar 2011
TodayJul 2026
First PostedDec 1, 2010
Enrollment StartDec 1, 2010
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.6 years ago
Interventions
Atorvastatindrug
Administered orally.
LY2189265biological
Administered subcutaneously.